Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: Can they be utilized as risk markers?

Clinical Oral Implants Research

Volumn 22, Issue 1, 2011, Pages 100-105

  Kwon, Yong Dae ^a   Ohe, Joo Young ^a   Kim, Deog Yoon ^b   Chung, Dong Jin ^c   Park, Yong Duk ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Bisphosphonate; C telopetide; CTX; ONJ; Osteocalcin; Osteonecrosis; Osteoporosis; Risk factor

Indexed keywords

ALENDRONIC ACID; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; OSTEOCALCIN; PEPTIDE;

AGED; ARTICLE; BLOOD; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; FEMALE; HUMAN; JAW DISEASE; MALE; MIDDLE AGED; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; ORAL SURGERY; OSTEOPOROSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; VALIDATION STUDY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ALENDRONATE; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; FEMALE; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEONECROSIS; OSTEOPOROSIS; PEPTIDES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGERY, ORAL;

EID: 78650207716     PISSN: 09057161     EISSN: 16000501     Source Type: Journal    
DOI: 10.1111/j.1600-0501.2010.01965.x     Document Type: Article

References (29)

1. Baim, S. & Miller, P.D. (2009) Assessing the clinical utility of serum ctx in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. Journal of Bone and Mineral Research 24: 561-574.
2. Bornstein, M.M., Cionca, N. & Mombelli, A. (2009) Systemic conditions and treatments as risks for implant therapy. The International Journal of Oral & Maxillofacial Implants 24 (Suppl.): 12-27.
3. Bowers, G.N. Jr. & McComb, R.B. (1975) Measurement of total alkaline phosphatase activity in human serum. Clinical Chemistry 21: 1988-1995.
4. Brown, J.P., Albert, C., Nassar, B.A., Adachi, J.D., Cole, D., Davison, K.S., Dooley, K.C., Don-Wauchope, A., Douville, P., Hanley, D.A., Jamal, S.A., Josse, R., Kaiser, S., Krahn, J., Krause, R., Kremer, R., Lepage, R., Letendre, E., Morin, S., Ooi, D.S., Papaioaonnou, A. & Ste-Marie, L.G. (2009) Bone turnover markers in the management of postmenopausal osteoporosis. Clinical Biochemistry 42: 929-942.
5. Chung, D., Chung, J., Cho, D. & Chung, M. (2008) The Premenopausal Reference Ranges of Bone Turnover Markers and the Effect of Bisphosphonates in Korean Postmenopausal Women 30th Conference of American Society of Bone and Mineral Research, S34. Montreal, Canada: American Society of Bone and Mineral Research.
6. Fall, P.M., Kennedy, D., Smith, J.A., Seibel, M.J. & Raisz, L.G. (2000) Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Osteoporosis International 11: 481-485.
7. Fink, E., Cormier, C., Steinmetz, P., Kindermans, C., Le Bouc, Y. & Souberbielle, J.C. (2000) Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Osteoporosis International 11: 295-303.
8. Fugazzotto, P.A., Lightfoot, W.S., Jaffin, R. & Kumar, A. (2007) Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. Journal of Periodontology 78: 1664-1669.
9. Grant, B.T., Amenedo, C., Freeman, K. & Kraut, R.A. (2008) Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. Journal of Oral and Maxillofacial Surgery 66: 223-230.
10. Hess, L.M., Jeter, J.M., Benham-Hutchins, M. & Alberts, D.S. (2008) Factors associated with osteonecrosis of the jaw among bisphosphonate users. American Journal of Medicine 121: 475-483, e473.
11. Jeffcoat, M.K. (2006) Safety of oral bisphosphonates: controlled studies on alveolar bone. The International Journal of Oral & Maxillofacial Implants 21: 349-353.
12. Khosla, S., Burr, D., Cauley, J., Dempster, D.W., Ebeling, P.R., Felsenberg, D., Gagel, R.F., Gilsanz, V., Guise, T., Koka, S., McCauley, L.K., McGowan, J., McKee, M.D., Mohla, S., Pendrys, D.G., Raisz, L.G., Ruggiero, S.L., Shafer, D.M., Shum, L., Silverman, S.L., Van Poznak, C.H., Watts, N., Woo, S.B. & Shane, E. (2008) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum ctx testing, prevention, and treatment. Journal of Oral and Maxillofacial Surgery 66: 1320-1321; author reply 1321-1322.
13. Kim, S.W., Park, D.J., Park, K.S., Kim, S.Y., Cho, B.Y., Lee, H.K. & Shin, C.S. (2005) Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis. Endocrinology Journal 52: 667-674.
14. Kwon, Y.D., Kim, D.Y., Ohe, J.Y., Yoo, J.Y. & Walter, C. (2009) Correlation between serum c-terminal cross-linking telopeptide of type i collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. Journal of Oral and Maxillofacial Surgery 67: 2644-2648.
15. Lehrer, S., Montazem, A., Ramanathan, L., Pessin-Minsley, M., Pfail, J., Stock, R.G. & Kogan, R. (2009) Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. Journal of Oral and Maxillofacial Surgery 67: 159-161.
16. Lo, J.C., O'Ryan, F.S., Gordon, N.P., Yang, J., Hui, R.L., Martin, D., Hutchinson, M., Lathon, P.V., Sanchez, G., Silver, P., Chandra, M., McCloskey, C.A., Staffa, J.A., Willy, M., Selby, J.V. & Gosdsd, A.S. (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. Journal of Oral and Maxillofacial Surgery 68: 243-253.
17. Looker, A.C., Bauer, D.C., Chesnut, C.H. III, Gundberg, C.M., Hochberg, M.C., Klee, G., Kleerekoper, M., Watts, N.B. & Bell, N.H. (2000) Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporosis International 11: 467-480.
18. Marx, R.E., Cillo, J.E. Jr. & Ulloa, J.J. (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum ctx testing, prevention, and treatment. Journal of Oral and Maxillofacial Surgery 65: 2397-2410.
19. Mavrokokki, T., Cheng, A., Stein, B. & Goss, A. (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. Journal of Oral and Maxillofacial Surgery 65: 415-423.
20. Qvist, P., Christgau, S., Pedersen, B.J., Schlemmer, A. & Christiansen, C. (2002) Circadian variation in the serum concentration of c-terminal telopeptide of type I collagen (serum CTX): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31: 57-61.
21. Raisz, L., Smith, J.A., Trahiotis, M., Fall, P., Shoukri, K., Digennaro, J. & Sacco-Gibson, N. (2000) Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. Osteoporosis International 11: 615-620.
22. Reid, I.R. (2009) Osteonecrosis of the jaw: who gets it, and why? Bone 44: 4-10.
23. Rizzoli, R., Burlet, N., Cahall, D., Delmas, P.D., Eriksen, E.F., Felsenberg, D., Grbic, J., Jontell, M., Landesberg, R., Laslop, A., Wollenhaupt, M., Papapoulos, S., Sezer, O., Sprafka, M. & Reginster, J.Y. (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42: 841-847.
24. Rosen, H.N., Moses, A.C., Garber, J., Iloputaife, I.D., Ross, D.S., Lee, S.L. & Greenspan, S.L. (2000) Serum ctx: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcified Tissue International 66: 100-103.
25. Ruggiero, S.L., Mehrotra, B., Rosenberg, T.J. & Engroff, S.L. (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. Journal of Oral and Maxillofacial Surgery 62: 527-534.
26. Shirota, T., Nakamura, A., Matsui, Y., Hatori, M., Nakamura, M. & Shintani, S. (2009) Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case. Clinical Oral Implants Research 20: 1402-1408.
27. Shoback, D. (2007) Update in osteoporosis and metabolic bone disorders. Journal of Clinical Endocrinology & Metabolism 92: 747-753.
28. Walter, C., Grotz, K.A., Kunkel, M. & Al-Nawas, B. (2007) Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Supportive Care in Cancer 15: 197-202.
29. Wang, H.L., Weber, D. & McCauley, L.K. (2007) Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. Journal of Periodontology 78: 584-594.